- Home
- MBNKP vs GALT Comparison
MBNKP vs GALT Comparison
Compare MBNKP & GALT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MBNKP
- GALT
- Stock Information
- Founded
- MBNKP N/A
- GALT 2000
- Country
- MBNKP United States
- GALT United States
- Employees
- MBNKP 135
- GALT N/A
- Industry
- MBNKP Commercial Banks
- GALT Biotechnology: Pharmaceutical Preparations
- Sector
- MBNKP Finance
- GALT Health Care
- Exchange
- MBNKP Nasdaq
- GALT Nasdaq
- Market Cap
- MBNKP N/A
- GALT 83.5M
- IPO Year
- MBNKP 2019
- GALT N/A
- Fundamental
- Price
- MBNKP $25.43
- GALT $2.18
- Analyst Decision
- MBNKP
- GALT Buy
- Analyst Count
- MBNKP 0
- GALT 2
- Target Price
- MBNKP N/A
- GALT $6.00
- AVG Volume (30 Days)
- MBNKP N/A
- GALT 1.4M
- Earning Date
- MBNKP N/A
- GALT 08-12-2025
- Dividend Yield
- MBNKP N/A
- GALT N/A
- EPS Growth
- MBNKP N/A
- GALT N/A
- EPS
- MBNKP N/A
- GALT N/A
- Revenue
- MBNKP N/A
- GALT N/A
- Revenue This Year
- MBNKP N/A
- GALT N/A
- Revenue Next Year
- MBNKP N/A
- GALT N/A
- P/E Ratio
- MBNKP N/A
- GALT N/A
- Revenue Growth
- MBNKP N/A
- GALT N/A
- 52 Week Low
- MBNKP N/A
- GALT $0.73
- 52 Week High
- MBNKP N/A
- GALT $3.90
- Technical
- Relative Strength Index (RSI)
- MBNKP 56.48
- GALT 56.31
- Support Level
- MBNKP $24.97
- GALT $2.08
- Resistance Level
- MBNKP $25.62
- GALT $2.66
- Average True Range (ATR)
- MBNKP 0.10
- GALT 0.53
- MACD
- MBNKP 0.02
- GALT -0.02
- Stochastic Oscillator
- MBNKP 72.06
- GALT 33.09
About MBNKP Medallion Bank Fixed-to-Floating Rate Non-Cumulative Perpetual Preferred Stock Series F
Medallion Bank is engaged in providing consumer loans, raising deposits, and managing other banking activities. It offers affordable financing for home improvement contractors, including window, siding, and roof replacements; kitchen, bath, and basement remodels; HVAC (Heating Ventilation and Air Conditioning), and solar PV installations. Medallion also offers recreation financing for new and used motorhomes, towable RVs, truck campers, cargo trailers, utility trailers, horse trailers, and a variety of ATVs and other power sport vehicles. Its segments are Recreation, Home Improvement, and Other. The company generates maximum revenue from the Recreation segment.
About GALT Galectin Therapeutics Inc.
Galectin Therapeutics Inc is a clinical-stage biopharmaceutical company. The company focuses on drug research and development to create new therapies for fibrotic disease, cancer, and selected other diseases. Its galectin-3 inhibitor is belapectin (GR-MD-02), which has been demonstrated in preclinical models to reverse liver fibrosis and cirrhosis.